CTU2 and liver cancer: To validate this, we conducted in vivo experiments and found that knocking down CTU2 expression in Hepa1-6 (mouse liver cancer cell line) significantly reduced the number of tumor lesions in liver cancer orthotopic models (Figures 6D, E).